Biotech Support Group Release
Biotech Support Group Helps Drive Innovation to ExpandProteomic Biomarkers Through a Full Range of Albumin & IgG Removal Products
Biotech Support Group reveals LC-MS focus on research & development on their Albumin Removal & IgG Products.
MONMOUTH JUNCTION, NJ, May28, 2019 -- Biotech Support Group (BSG), a leading provider of proteomic sample prep and enrichment products and services, reveals LC-MS focus on research and development on their Albumin Removal Products as highlighted on their new webpage, www.biotechsupportgroup.com/Albumin-Removal.
Driving innovation through cost effective andefficient sample prep methods, BSG’s base of Albumin & IgG Removal Productsare essential for expanding proteomic biomarkers into routine healthcare. Witha LC-MS knowledgebase of over 1000 serum proteins, they are equipped to supporttargeted and quantitative protein biomarkers from blood, serum or plasma.
Dr. Swapan Roy, Ph.D., President and Founderof Biotech Support Group, states, “With biomarker research at our core, weunderstand all the sample prep challenges of serum proteomics. We are the firstcompany to really establish quantitative LC-MS bias characteristics of not onlyproteome separations but also digest conditions. So we think our knowledgebase willbe extremely helpful to assist our customers develop the next generation ofproteomic innovation.”
Additionally, Biotech Support Group hasrecently reported on research, presented as a technical poster report andhighlighted at the 26th Annual International Molecular Med TRI-CON, held March10-15, 2019 in San Francisco, CA USA. The research shows that serum proteomicworkflows can be especially challenging due to the presence of highly abundantproteins and background signal from antibody derived peptides. Consequently,researchers need ways to enrich differently. Without any requirement forimmuno-affinity, BSG has developed a full range of Albumin & IgG RemovalProducts to overcome the challenges of clinical proteomics.
The company’s most recent application reporthighlights the serum proteome bias characteristics of AlbuVoid™ & NuGel™Protein A, alone or in serial combination, using LC-MS reporting metrics. The posterpresentation was entitled "AlbuVoid™ Enrichment & Antibody Depletion – Tacklingthe Challenges of Serum Proteomics Part II", co-authored withcollaborators from the Rutgers Proteomics Center. Clickhere to download.
Previously, Biotech Support Group has reportedon a variety of tools that can bias towards or against select sub-proteomes ofserum without the use of immuno-affinity. This has led to success in thecompany’s own LC-MS discovery programs, most notably a patent pending panel ofcancer serum biomarkers called StromaLiquid Biopsy™.
"After many years of optimizing ourunique bead-based enrichment methods, we can offer two diverse separationstrategies, either a binding or a voiding strategy. These are all consumableproducts suitable for all proteomic analytical platforms, from LC-MS tofunctional assays. We are very pleased to report these significant discoveriesto help solve the challenges of serum proteomics,” states Dr. Swapan Roy, Ph.D.
“Products and digest conditions producedifferent proteome qualitative and quantitative windows of observation. In ourown discovery efforts, we have demonstrated the value for enrichment ofcategorical sub-proteomes to provide mechanistic insight into diseasepathologies”, reports Matthew Kuruc, Vice President Business Development and co-authorof the report. “With a knowledgebase of over 1000 serum proteins, now we canhelp proteomic researchers choose the best available products and methods fortheir particular needs.”
Formore information on the BSG complete line of Albumin & IgG Removalproducts, click this link.
About Biotech Support Group LLC
Convergingwith cultural and technological disruptions forthcoming in healthcare, BiotechSupport Group develops methods for cost effective and efficient sample prepessential for these expanding markets. Following a tiered business strategy,the company continues its growth in the consumable research products areasupporting the rapidly expanding installation of LC-MS instrument andcomputational infrastructure. For this market, key products include: AlbuVoid™and AlbuSorb™ for albumin depletion, Cleanascite™ for lipid adsorption,HemogloBind™ and HemoVoid™ for hemoglobin removal, and NuGel™ for functionalproteomics. From these innovations, the company has acquired knowledgebase andbiomarker intellectual property assets that support discoveries of proteinmarkers from blood, with special emphasis on early detection and personalizedmedical decisions for cancer patients. For more information, go to https://www.biotechsupportgroup.com/
Contact: Matthew Kuruc732-274-2866, [email protected]